Metabolomics for the Identification of Biomarkers in Rheumatoid Arthritis.
This paper utilizes metabolomics to identify biomarkers specifically for rheumatoid arthritis, without establishing a connection to endometriosis or adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This review article examines the utility of metabolomics in identifying biomarkers for rheumatoid arthritis, focusing on metabolic disruptions in amino acids and lipids that reflect disease progression and drug response. The authors highlight that current serological markers like ACPA and RF lack specificity, leading to diagnostic challenges, particularly in seronegative patients. They discuss how techniques such as NMR and mass spectrometry can detect distinct metabolic profiles associated with inflammation and treatment efficacy from agents like methotrexate and Janus kinase inhibitors. Relevance to endometriosis: listed as one indication for metabolomic studies alongside other conditions, though the paper's main focus is rheumatoid arthritis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
9,202 characters
· extracted from
oa-html
· 2 sections
· click to expand
Acknowledgements
References
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-09-20T09:27:46.357103+00:00
- unpaywall
- last seen: 2026-09-23T06:15:37.550144+00:00